Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Real-time, Contextual Intervention Using Mobile Technology to Reduce Marijuana Use in Youth (MOMENT)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2013 by Children's Hospital Boston
Sponsor:
Information provided by (Responsible Party):
Lydia Shrier, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT01762696
First received: January 4, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted
  Purpose

The purpose of this study is to further develop and test the Momentary Self-Monitoring and Feedback + Motivational Enhancement Therapy (MOMENT) intervention, a real-time, contextual intervention to reduce marijuana use among primary care patients.


Condition Intervention
Marijuana Abuse
Behavioral: MET
Behavioral: Mobile self-monitoring
Behavioral: Motivational feedback messages

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: A Real-time, Contextual Intervention Using PDAs to Reduce Marijuana Use in Youth

Resource links provided by NLM:


Further study details as provided by Children's Hospital Boston:

Primary Outcome Measures:
  • Marijuana desire [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Desire to use marijuana when in top-3 trigger context

  • Marijuana use following trigger exposure [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Marijuana use following exposure to top-3 trigger context

  • Frequency of marijuana use [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Marijuana use events/day

  • Percent days abstinent [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    30-day percent days abstinent from marijuana use

  • Motivation to reduce marijuana use [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Daily score on 3 scales - readiness to reduce marijuana use, importance of reducing use, and confidence in ability to reduce use


Estimated Enrollment: 108
Study Start Date: January 2013
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: MET only
Motivational Enhancement Therapy only
Behavioral: MET
Other Name: Motivational Enhancement Therapy
Experimental: No feedback
Motivational Enhancement Therapy + momentary and daily mobile self-monitoring, but no feedback on triggers or use behaviors
Behavioral: MET
Other Name: Motivational Enhancement Therapy
Behavioral: Mobile self-monitoring
Experimental: MOMENT
The full MOMENT intervention: Motivational Enhancement Therapy + momentary and daily mobile self-monitoring + motivational feedback messages prompting participants to consider their individualized coping strategies to avoid using marijuana
Behavioral: MET
Other Name: Motivational Enhancement Therapy
Behavioral: Mobile self-monitoring Behavioral: Motivational feedback messages

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   15 Years to 24 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male or female between the ages of 15-24 years
  • Patient of the Boston Children's Hospital Adolescent/Young Adult Medicine Clinic or Martha Elliot Health Center Adolescent Clinic
  • Ability to read and understand English

Exclusion Criteria:

  • Medically or emotionally unstable, intoxicated or "high,", or otherwise unable to give consent at the time of their appointment
  • Have previously participated in this study
  • Does not meet the above inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01762696

Contacts
Contact: Allegra Spalding, BS 617-355-2668 allegra.spalding@childrens.harvard.edu
Contact: Lydia A Shrier, MD, MPH 617-355-8306

Locations
United States, Massachusetts
Boston Children's Hospital Adolescent/Young Adult Medical Clinic Not yet recruiting
Boston, Massachusetts, United States, 02115
Martha Eliot Health Center Adolescent Clinic Not yet recruiting
Jamaica Plain, Massachusetts, United States, 02130
Sponsors and Collaborators
Children's Hospital Boston
Investigators
Principal Investigator: Lydia A Shrier, MD, MPH Children's Hospital Boston
  More Information

No publications provided

Responsible Party: Lydia Shrier, Attending Physician, Adolescent Medicine, Children's Hospital Boston
ClinicalTrials.gov Identifier: NCT01762696     History of Changes
Other Study ID Numbers: 1R34DA030535-01A1
Study First Received: January 4, 2013
Last Updated: January 4, 2013
Health Authority: United States: Data and Safety Monitoring Board
United States: Federal Government
United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
marijuana
intervention
adolescent, young adult
primary care
mobile

Additional relevant MeSH terms:
Marijuana Abuse
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders

ClinicalTrials.gov processed this record on November 25, 2014